Wednesday, April 6, 2016

Ackman Defends Pershing Square’s Large Stake in Valeant by LANDON THOMAS Jr.


By LANDON THOMAS Jr.

William A. Ackman said the drug company Valeant was undervalued and had potential but its decline had affected his firm, Pershing Square.

Published: April 7, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1ROMzLN



from WordPress http://ift.tt/1SQmWMU
via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)